Androglobin knockdown inhibits growth of glioma cell lines

Bo Huang; Yi-Sheng Lu; Xia Li; Zhi-Chuan Zhu; Kui Li; Ji-Wei Liu; Jing Zheng; Ze-Lan Hu
May 2014
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 5, p2179
Academic Journal
No abstract available.


Related Articles

  • Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Benjamin W. Purow; Tilak K. Sundaresan; Michael J. Burdick; Benjamin A. Kefas; Laurey D. Comeau; Michael P. Hawkinson; Qin Su; Yuri Kotliarov; Jeongwu Lee; Wei Zhang; Howard A. Fine // Carcinogenesis;May2008, Vol. 29 Issue 5, p918 

    The Notch pathway plays a key role in the development and is increasingly recognized for its importance in cancer. We demonstrated previously the overexpression of Notch-1 and its ligands in gliomas and showed that their knockdown inhibits glioma cell proliferation and survival. To elucidate the...

  • FasL gene knock-down therapy enhances the antiglioma immune response. Jansen, Timothy; Tyler, Betty; Mankowski, Joseph L.; Recinos, Violette Renard; Pradilla, Gustavo; Legnani, Federico; Laterra, John; Olivi, Alessandro // Neuro-Oncology;May2010, Vol. 12 Issue 5, p482 

    Malignant glioma is a lethal form of brain cancer that is very difficult to treat. The aggressive behavior of these neoplasms and their limited responsiveness to therapy has been attributed in part to the ability of these tumors to evade the immune system. Gliomas, like many other solid tumors,...

  • Diversin is overexpressed in human gliomas and its depletion inhibits proliferation and invasion. Wang, Minghao; Yu, Xinmiao; Dong, Qianze; Wang, Yunjie // Tumor Biology;Aug2014, Vol. 35 Issue 8, p7905 

    Previous study indicated diversin overexpression in human cancers. However, its expression pattern in human gliomas and the molecular mechanisms of diversin on cancer progression have not been characterized. In the present study, diversin expression was investigated in 105 glioma specimens using...

  • EFEMP2 is upregulated in gliomas and promotes glioma cell proliferation and invasion. Long Wang; Qianxue Chen; Zhibiao Chen; Daofeng Tian; Haitao Xu; Qiang Cai; Baohui Liu; Gang Deng // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 9, p10385 

    Gliomas are the most common and aggressive form of primary brain tumor. Although EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2), an extracellular matrix (ECM) glycoprotein, is regarded as a candidate oncogene, little is known about the association of EFEMP2 and gliomas....

  • RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3. Wei Han; Zhongshuai Xin; Zhiqiang Zhao; Wen Bao; Xihua Lin; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng // Journal of Clinical Investigation;May2013, Vol. 123 Issue 5, p2103 

    PCBP2 is a member of the poly(C)-binding protein (PCBP) family, which plays an important role in posttranscriptional and translational regulation by interacting with single-stranded poly(C) motifs in target mRNAs. Several PCBP family members have been reported to be involved in human...

  • Identification of the role of Smad interacting protein 1 (SIP1) in glioma. Microgene Xia; Minghua Hu; Jun Wang; Yajun Xu; Xiaobing Chen; Yuedong Ma; Lei Su // Journal of Neuro-Oncology;Apr2010, Vol. 97 Issue 2, p225 

    Glioma is an extremely aggressive and lethal form of brain cancer. Despite recent advances in diagnostics and treatments, prognosis for advanced patients suffering from these diseases remains poor. Therefore, identification of new therapeutic targets for glioma is of significant importance. In...

  • Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity. Zhang, Danfeng; Dai, Dawei; Li, Zhenxing; Wang, Chunhui; Lu, Yicheng; Li, Yiming; Wang, Junyu; Zhou, Mengxia // Cellular Physiology & Biochemistry (Karger AG);2018, Vol. 51 Issue 6, p2496 

    Background/Aims: Cyclin D1 (CCND1) is frequently overexpressed in malignant gliomas. We have previously shown ectopic overexpression of CCND1 in human malignant gliomas cell lines. Methods: Quantitative reverse transcriptase PCR (qRT-PCR) and Western Blot (WB) was performed to investigate the...

  • HGF upregulates CXCR4 expression in gliomas via NF-κB: implications for glioma cell migration. Esencay, Mine; Newcomb, Elizabeth W.; Zagzag, David // Journal of Neuro-Oncology;Aug2010, Vol. 99 Issue 1, p33 

    Invasion is a hallmark of malignant gliomas and is the main reason for therapeutic failure and recurrence of the tumor. CXCR4 is a key chemokine receptor implicated in glioma cell migration whose expression is regulated by hypoxia. Here, we report that hepatocyte growth factor (HGF) upregulated...

  • Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas. Ruokun, Chen; Yake, Xue; Fengdong, Yang; Xinting, Wei; Laijun, Song; Xianzhi, Liu // Tumor Biology (Springer Science & Business Media B.V.);Nov2016, Vol. 37 Issue 11, p15065 

    Gliomas are the most common type of malignant brain tumors, and the related prognosis is poor. Though many genes have been identified as factors in the development and progression of gliomas, underlying mechanisms remained unclear. It was clear that abnormal lipid metabolism was one of the major...

  • TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells. Fu, Jun; Yang, Qun-ying; Sai, Ke; Chen, Fu-rong; Pang, Jesse C.S.; Ng, Ho-keung; Kwan, Aij-lie; Chen, Zhong-ping // Neuro-Oncology;Oct2013, Vol. 15 Issue 10, p1353 

    Background CD44 is a molecular marker associated with cancer stem cell populations and treatment resistance in glioma. More effective therapies will result from approaches aimed at targeting glioma cells high in CD44. Methods Glioma-initiating cell lines were derived from fresh surgical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics